Dublin, April 01, 2019 (GLOBE NEWSWIRE) -- The "Saudi Arabia In-Vitro Diagnostics (IVD) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The Saudi Arabia in-vitro diagnostics (IVD) market was worth US$ 650 Million in 2018

Saudi Arabia currently represents the largest market for in-vitro diagnostics in the GCC region. In-vitro diagnostics, plays a significant role in in the Saudi Arabia healthcare system by providing accurate diagnosis and prognosis, which enables improved monitoring and treatment. Diagnostics represent only a small share of the total healthcare spending but are critical in medical decision making and reducing the burden of diseases and healthcare expenditures.

There has been a steady growth in the adoption of in-vitro diagnostics in Saudi Arabia. Increasing incidence rates of various infectious and chronic diseases represent some of the key drivers of the in-vitro diagnostics market in Saudi Arabia. The country's population is currently around 33 Million and is growing annually at around 2%.

According to Saudi Arabia's General Authority of Statistics, elderly constituted 4.2% of the total Saudi population and are expected to increase further in the coming years. With an increasing elderly population, we expect the prevalence of a number of chronic diseases to increase significantly in the next few years.

Moreover, catalyzed by rising physical inactivity and consumption of unhealthy diets, the prevalence of a number of lifestyle diseases have been increasing in the country. Saudi Arabia has one of the highest rates of obesity in the world. It is estimated that around 36% of the total population are obese. Additionally, the prevalence of hypertension was around 29% among males and around 24% among females.
Saudi Arabia also has one of the highest prevalence of diabetes with around 19% of the adult population suffering from diabetes in the country. Some of the other factors catalyzing the growth of in-vitro diagnostics in Saudi Arabia include rising healthcare expenditures, improving healthcare infrastructure, initiatives by the government, rising awareness levels, etc.

Looking forward, the market is further projected to reach a value of US$ 1,020 Million by 2024, growing at a CAGR of around 8% during 2019-2024.

Key Questions Answered in This Report:

• How has the Saudi Arabia in-vitro diagnostics (IVD) market performed so far and how will it perform in the coming years?
• What are the key application segments in the Saudi Arabia in-vitro diagnostics (IVD) market?
• What are the major end-users in the Saudi Arabia in-vitro diagnostics (IVD) market?
• What are the various stages in the value chain of the Saudi Arabia in-vitro diagnostics (IVD) market?
• What are the key driving factors and challenges in the Saudi Arabia in-vitro diagnostics (IVD) market?
• What is the degree of competition in the Saudi Arabia in-vitro diagnostics (IVD) market?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Saudi Arabia In-Vitro Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by End-User
5.4 Market Breakup by Application
5.5 Market Forecast
5.6 SWOT Analysis
5.7 Value Chain Analysis
5.8 Porters Five Forces Analysis

6 Market Breakup by End-User
6.1 Hospital-Based Centres
6.2 Diagnostics Chains
6.3 Standalone Centres
6.4 Others

7 Market Breakup by Application
7.1 Infectious Diseases
7.2 Diabetes
7.3 Blood Test
7.4 Nephrology
7.5 Cardiology
7.6 Oncology
7.7 Autoimmune Diseases
7.8 Others

8 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/s2z9rw/saudi_arabia?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.